Newsletter | January 20, 2023

01.20.23 -- Companies To Watch: Ocelot Bio

Featured Articles
Defining The RNA Therapeutics Industry In 2023

Four executives outline which industry challenges, strategic considerations, and opportunities should be top of mind as RNA therapeutics companies establish their to-do lists for 2023.

Companies To Watch: Ocelot Bio

Ocelot Bio is focusing a single drug on multiple complications of end-stage liver disease.

The Next Big Thing

Each January, the J.P. Morgan healthcare conference helps to set the biopharma industry agenda for the coming year. What will be the next big thing in 2023?

Web-Exclusive Content
5 Steps To Eliminate Weak Links In Your Data Governance

Major regulators, including the FDA and EMA, have established frameworks through which data must be captured and exchanged with them. But your pharma, biotech, or medical device company needs a solid plan for how that data will be governed.

Industry Insights
How An AI/ML Data Strategy For Life Sciences Can Deliver Better Business Outcomes

Explore how data science and artificial intelligence/machine learning (AI/ML) driven predictive and prescriptive insights can help research teams cut the time and cost.

Large-Scale LVV Production: Process Development To GMP Vector

Explore the key advantages of a proven approach to scale the lentiviral vector (LVV) production process (48L cf) in a bioreactor (200 L) without changing critical quality attributes (CQAs).

The Top 10 Most Cited QSR Clauses In FDA FY2022 Medical Device Inspections

The number of Notices of Inspectional Observation (Forms 483 (i.e., 483s)) issued against medical device manufacturers in FY2022 was 538 compared to 191 in FY2021, an increase of almost 200%. Take a more detailed look into these 483s.

Digital Edition
January 2023 Digital Edition

Inside you will find more on:

  • Verve Therapeutics CEO Interview
  • CEO Corner
  • Ask The Board
  • Partnership Tips

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.